de Gasperi et al. (1996) also found lower plasma propofol concentrations in patients with severe renal impairment, attributed to increased phenol-induced glucuronosyltransferase activity, enhanced glucuronic acid binding, and accelerated hepatic biotransformation in patients with renal dysfunction patients. This evidence concerns the gene B3GAT2 and Abnormal renal physiology.